Brain Scientific (OTCQB: BRSF) is focused on developing innovative and proprietary medical devices and software. As the company works to modernize brain diagnostics through cutting-edge tech, it has also collaborated with Marketing Brainology, a neuromarketing firm that uses neuroscience to understand consumer behavior.
In 2019, Marketing Brainology conducted a test to measure Super Bowl advertisements’ impact using the NeuroCap, disposable EEG headset and NeuroEEG, a 16-channel EEG amplifier and software along with in-depth interviews and eye-tracking software; the study was repeated in 2020, confirming that one size does not fit all with consumers. The company also released a video that shows the NeuroCap in action as Marketing Brainology studies consumers’ emotional reactions to these ads (https://ibn.fm/warLu).
Marketing Brainology uses neuroscience to identify decision triggers in the human brain. The same methods used to identify Super Bowl ads’ impact was used to determine the most effective messaging for dispensing COVID-19 messaging in 2020. Inspirational messages, particularly those from doctors and nurses, were better received than alarming messages. In fact, negative dramatic messaging was more likely to be tuned out than the empathetic and inspirational messages of hope.
“These methods unlock doors regarding human nature when a crisis is at hand,” said Marketing Brainology president Michelle Adams (https://ibn.fm/An0pL). “This information supplies invaluable data for the current situation we face as well as how we should navigate the future.” Brain Scientific interviewed Adams regarding Brainology’s experience using the Brain Scientific’s EEG equipment to measure consumers’ brain activity and emotional response.
Adams pointed out several features that were important in choosing this partnership. These features include medical-grade equipment; easy setup, which is crucial for subjects with long and thick hair; not clunky or pricey; and continued dedication toward improvement
“Overall, what I admire about MemoryMD’s (a subsidiary of Brain Scientific Inc.) team is that they took the time to develop the technology,” stated Adams. “I am sure they could have rushed to market a lot sooner, but they went through their own checks and balances. Because they are medically driven… I have 100% faith that [BRSF’s] technology is top of the line — and the medical community would not accept something less. For what we need it is more than enough in terms of quality and accuracy.”
For more information, visit the company’s website at www.BrainScientific.com.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Cancer statistics underscore the urgency of ongoing cancer research and the need for more effective…
A team of researchers has leveraged a technique called temporal learning to train an AI…
Sheridan was recently named as a finalist for the 2025 EY Entrepreneur of the Year…
“Research on the treatment of cancer is fundamental to improving outcomes for all patients affected…
Adageis offers an AI-powered financial technology platform tailored to healthcare providers seeking a financially positive…
A new study focusing on twins has found that individuals with a larger presence of…